STRENGTH IN NUMBERS

Strength in Numbers dedicated to my late mother Kay

NHS should stop buying drugs which cost more than £13,000, researchers say

Cutting funding on drugs would stop people with terminal illnesses having the chance to live that much longer, and closing the door on most new treatments. Lets hope it never comes to that. Joanna

 The NHS should not spend more than £13,000 a year on drugs for individuals because higher spending does “more harm than good” by diverting funds from larger groups of patients, economists have said. A study by the Centre of Health Economics, at the University of York, says health spending on costly drugs, especially those which prolong the lives of terminally-ill cancer patients, is not an effective use of NHS resources, and says costs should be capped much lower. But health watchdogs last night hit out at the research, and said following the advice would mean “closing the door” on the majority of new drugs for patients. Under current NHS guidance, the National Institute of Health and Care Excellence rarely backs drugs which cost more than around £40,000 a year, but cancer drugs which cost more can be funded via a special NHS Cancer Drugs Fund.

It means breast cancer drugs such as Kadcyla, which costs around £90,000 a year, and can extend life by an average of six months, in those for whom it is suitable, are funded by the NHS, despite their high costs.

Click on the link to read more

http://www.telegraph.co.uk/news/uknews/11421013/NHS-should-stop-buying-drugs-which-cost-more-than-13000-researchers-say.html

prescription_2496644b[1]

Debate about which drugs the NHS should fund has been hotly debated  Photo: Alamy 

Filed under: NHS, , , ,

Blog views to date

  • 111,608 hits

Enter your email address to subscribe to The Last Six Months and receive notifications of new posts by email.

Join 1,421 other followers

Recent Posts